Sam Poser

The analyst maintains a BUY rating on NKE, citing they are "doing the right things" and he likes what he's seeing, despite lowering his price target due to a slower-than-expected turnaround. The prior strategy severely damaged wholesale relationships and product pipelines. The new management is rebuilding this support structure, which is leading to concrete improvements in sell-through rates and retailer relationships, particularly in North America. The operational "fracture" is healing, and the company is on the correct strategic path. The current low stock price presents a long-term opportunity as these corrective actions gradually restore health to the business. The recovery timeline remains uncertain and could be further delayed, especially in the critical China market. Continued execution missteps or a failure to reaccelerate growth would break the thesis.

Wholesale demand in the US and international markets is weak. The company is opening 200-250 new stores to offset this weakness. Opening stores to mask wholesale weakness is a red flag. It increases fixed costs (rent/labor) while the core brand demand is eroding. This suggests management is forcing growth rather than it being organic. SHORT CROX due to deteriorating fundamentals and margin compression risk. Share buybacks could artificially prop up the stock price.